Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2003
05/22/2003CA2467229A1 Dexrazoxane for treating antitumor-induced cardiotoxicity
05/22/2003CA2467052A1 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003CA2467032A1 Method to obtain protection against bystander allergen
05/22/2003CA2466843A1 Salmonella vaccine
05/22/2003CA2466641A1 Lyophilized monoclonal antibody compositions
05/22/2003CA2466592A1 Modified anti-tnf alpha antibody
05/22/2003CA2466118A1 Modulation of lir function to treat rheumatoid arthritis
05/22/2003CA2466043A1 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003CA2465304A1 Composition comprising inhibitors of the notch signalling pathway for the modulation of the immune system
05/22/2003CA2460959A1 Enzymes
05/21/2003EP1312679A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312678A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312670A1 Method of extensive culture of antigen-specific cytotoxic t cells
05/21/2003EP1312377A2 Combined meningitis vaccine
05/21/2003EP1312359A2 Use for 1,3-propanediol compounds
05/21/2003EP1311699A2 Adeno-associated virus-mediated delivery of angiogenic factors
05/21/2003EP1311698A2 Porcine adenovirus type 5 vector and vaccine
05/21/2003EP1311694A1 Pyruvate:nadp+ oxidoreductase and uses thereof
05/21/2003EP1311691A2 Method and compositions for promoting osteogenesis
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311682A2 Recombinant constructs of borrelia burgdorferi
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311678A2 Cripto tumour polypeptide
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311675A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311665A2 Kidney-specific protein
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311658A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
05/21/2003EP1311549A2 Composition for the elimination of autoreactive b-cells
05/21/2003EP1311547A2 Diagnosis and treatment of cardiovascular conditions
05/21/2003EP1311542A2 Peptide selection method
05/21/2003EP1311541A1 IMMUNOGENIC PROTEINS DERIVED FROM DOMESTIC MITE ALLERGEN, BLOMIA TROPICALIS (Bt5)
05/21/2003EP1311540A2 Altered ospa of borrelia burgdorferi
05/21/2003EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
05/21/2003EP1311536A2 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies
05/21/2003EP1311522A1 New immunoeffector compounds
05/21/2003EP1311298A2 System for regulating in vivo the expression of a transgene by conditional inhibition
05/21/2003EP1311297A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311290A2 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
05/21/2003EP1311289A2 Vaccines containing ribavirin and methods of use thereof
05/21/2003EP1311288A1 Immunostimulatory nucleic acids for inducing a th2 immune response
05/21/2003EP1311282A1 High affinity integrin polypeptides and uses thereof
05/21/2003EP1311278A1 Method and composition for immunization using mixed pools of mutated nucleic acids or peptides
05/21/2003EP1311267A1 A retroviral immunotherapy
05/21/2003EP1017367B1 Methods for fabricating polymer-based controlled release preparations
05/21/2003EP1015593B1 Hepatitis b virus polypeptides
05/21/2003EP0918528B1 Use of hyperimmunized milk and/or egg for treating gastrointestinal damage
05/21/2003EP0876613B1 Treatment and diagnosis of infections due to helicobacter pylori
05/21/2003EP0837699B1 Immunovectors for the intracellular and intranuclear transport
05/21/2003EP0633931B1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
05/21/2003CN1419564A Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
05/21/2003CN1419456A Vaccine for the prophylactic or therapeutic immunization against HIV
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
05/21/2003CN1109102C Needleless syringe using supersonis gas flow for particle delivery
05/21/2003CN1109049C Adjuvent composition containing cyclodextrin and vaccine having same
05/21/2003CN1109046C Induction of cytotoxic T-lymphocyte responses
05/21/2003CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof
05/21/2003CN1108821C Preparation of multiepitope-epitope vaccine
05/21/2003CN1108820C Preparation of epitope vaccine with single monoepitope or multiple monoepitope duplication
05/21/2003CN1108819C Preparation of dissociation-resisting epitope vaccine
05/21/2003CN1108818C Activated immune globulin
05/21/2003CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
05/21/2003CN1108789C Liposomes contg. particulate materials
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566502 Diagnosing mammary gland or colon and rectum cancer; obtain tissue sample, monitor preferential gene expression, compare to control, evaluate adjustments in gene expression, diagnos for cancer
05/20/2003US6566500 Compositions and methods for modifying toxic effects of proteinaceous compounds
05/20/2003US6566386 Treating autoimmune diseases (rheumatism, systemic lupus, erythematosus, multiple sclerosis, and AIDS), inflammation, and suppressing eosinophilia via administering histamine admixed with gamma-globulin
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566324 Preventing airway mucus production by administration of EGF-R antagonists
05/20/2003US6566121 Genetically engineered microorganism for use as tools in the generation and expression of heterolgous proteins
05/20/2003US6566095 Blocking transmission of viral particles to animals; obtain animal, administer antibody, incubate with viral sample, monitor viral infection, reduction in viral infection indicates antagonist
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6566085 Synthetic peptides, antibodies directed against them, and the use thereof
05/20/2003US6566084 Detecting hydrolysis of cocaine compound; obtain cocaine mixture, incubate with antibody, monitor generation of benzoic zacid
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6566078 36P6D5: secreted tumor antigen
05/20/2003US6566072 Diagnosing mammary gland cancer in humans; obtain tissue sample, recover proteins, incubate with antibody, detect presence bound antibody, amplified presence of boubd antibody indicates cancer
05/20/2003US6566066 Aquaporin-8 variant
05/20/2003US6566052 Efficient algorithm for PCR testing of blood samples
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565855 Polypeptides; genetic engineering
05/20/2003US6565854 Killing microorganisms, especially human pathogens; use in would dressings; animal feeds; vaccines
05/20/2003US6565853 Induction immunology response; genetic engineering
05/20/2003US6565852 Tumor antigen; vaccine; antitumor, anticarcinogenic agents
05/20/2003US6565851 Relieving symptoms of erectile dysfunction with proanthocyanidins
05/20/2003US6565849 Methods of enhancing activity of vaccines and vaccine compositions
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003US6565831 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/20/2003CA2223579C Novel recombinant temperature sensitive mutants of influenza
05/20/2003CA2131551C Conjugates formed from heat shock proteins and oligo- or polysaccharides
05/15/2003WO2003040726A2 Screening for hepatitis c virus entry inhibitors
05/15/2003WO2003040723A1 Method for rehabilitating an organism with slow viral infection
05/15/2003WO2003040384A1 Recombinant antibodies for the detection and neutralization of anthrax toxin
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040340A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
1 ... 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 ... 1823